Expertise in
7
conditions

Dr. Patricia C. Griffin

Radiation Oncology
101 E Wood St, 
Spartanburg, SC 
Expertise in
7
conditions
101 E Wood St, 
Spartanburg, SC 

Overview

Patricia Griffin is a Radiation Oncologist in Spartanburg, South Carolina. Dr. Griffin is highly rated in 7 conditions, according to our data. Her top areas of expertise are Breast Cancer, Small Cell Lung Cancer (SCLC), Angiosarcoma, and Squamous Cell Lung Carcinoma.

Her clinical research consists of co-authoring 3 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Radiation Oncology

Licenses

Radiology in SC

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D

Locations

101 E Wood St, Spartanburg, SC 29303

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 06, 2026
Intervention Type: Biological, Radiation
Study Drug: Cetuximab
Study Phase: Phase 3
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Enrollment Status: Active_not_recruiting
Publish Date: November 25, 2025
Intervention Type: Radiation, Drug
Study Drugs: Docetaxel, Gemcitabine, Pemetrexed Disodium, Erlotinib Hydrochloride, Pembrolizumab
Study Phase: Phase 2
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Enrollment Status: Active_not_recruiting
Publish Date: November 19, 2025
Intervention Type: Other, Drug, Radiation
Study Drugs: Cisplatin, Fluorouracil, Gemcitabine Hydrochloride, Paclitaxel
Study Phase: Phase 2/Phase 3
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Enrollment Status: Active_not_recruiting
Publish Date: October 28, 2025
Intervention Type: Radiation
Study Phase: Phase 3
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
Enrollment Status: Completed
Publish Date: October 08, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Capecitabine, Chemotherapy, Erlotinib hydrochloride, Fluorouracil, Gemcitabine hydrochloride
Study Phase: Phase 3
Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer - A Collaborative Study of NRG Oncology and KROG
Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer - A Collaborative Study of NRG Oncology and KROG
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Other, Radiation, Drug
Study Drug: Lapatinib Ditosylate
Study Phase: Phase 2
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide
Enrollment Status: Unknown
Publish Date: June 12, 2023
Intervention Type: Drug, Radiation
Study Drugs: Cisplatin, Etoposide, Carboplatin
Study Phase: Phase 3
A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III Non-small Cell Lung Cancer (NSCLC)
A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III Non-small Cell Lung Cancer (NSCLC)
Enrollment Status: Terminated
Publish Date: August 05, 2019
Intervention Type: Drug, Radiation
Study Phase: Phase 2
View 7 Less Clinical Trials

3 Total Publications

Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance).
Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance).
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: January 27, 2017
Similar Doctors
Expertise in
51
conditions
Dr. Heather N. Allen
Radiation Oncology
Expertise in
51
conditions
Dr. Heather N. Allen
Radiation Oncology

Spartanburg Medical Center

101 E Wood St, 
Spartanburg, SC 
 (0.1 miles away)
864-560-6917
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Heather Allen is a Radiation Oncologist in Spartanburg, South Carolina. Dr. Allen is highly rated in 51 conditions, according to our data. Her top areas of expertise are Teratocarcinosarcoma, Olfactory Neuroblastoma, Lung Cancer, and Pleuropulmonary Blastoma. Dr. Allen is currently accepting new patients.

Expertise in
22
conditions
Dr. Drew C. Monitto
Radiation Oncology
Expertise in
22
conditions
Dr. Drew C. Monitto
Radiation Oncology

Spartanburg Medical Center

101 E Wood St, 
Spartanburg, SC 
 (0.1 miles away)
864-560-6917
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Drew Monitto is a Radiation Oncologist in Spartanburg, South Carolina. Dr. Monitto is highly rated in 22 conditions, according to our data. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Posterior Fossa Tumor, and Lung Cancer. Dr. Monitto is currently accepting new patients.

Expertise in
23
conditions
Dr. Daniel B. Fried
Radiation Oncology
Expertise in
23
conditions
Dr. Daniel B. Fried
Radiation Oncology

Spartanburg Medical Center

101 E Wood St, 
Spartanburg, SC 
 (0.1 miles away)
864-560-6917
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Daniel Fried is a Radiation Oncologist in Spartanburg, South Carolina. Dr. Fried is highly rated in 23 conditions, according to our data. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Astrocytoma, and Lung Cancer. Dr. Fried is currently accepting new patients.

Frequently Asked Questions about Dr. Patricia C. Griffin

How do I make an appointment with Dr. Patricia C. Griffin?

You can book an appointment with Dr. Patricia C. Griffin by calling their office at 864-560-6917. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Patricia C. Griffin a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Patricia C. Griffin is classified as an Advanced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Patricia C. Griffin specialize in?

While Dr. Patricia C. Griffin is a Radiation Oncology, they have specific expertise in Breast Cancer, Small Cell Lung Cancer (SCLC), and Angiosarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Patricia C. Griffin participate in research or clinical trials?

Yes. Dr. Patricia C. Griffin has published 3 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Patricia C. Griffin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Patricia C. Griffin accept my insurance?

Dr. Patricia C. Griffin accepts most major insurance plans, including Medicare. We recommend calling the office directly at 864-560-6917 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Griffin's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 38 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile